Study of Everolimus (RAD001) in Patients With Recurrent Glioblastoma Multiforme (GBM)
Clinical trial NCT00515086 · TERMINATED
Trial details
- NCT number
- NCT00515086
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-08-01
- Primary completion
- 2009-08-01
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.